genomics market

Top Reports

This edition of the Genetic Technology TOE depicts life sciences trends across genomics. Discovery of genetic risk factors for common complex diseases, an artificial intelligence platform for assembling biological data, advancing precision oncology via whole genome sequencing, and cutting edge adjacent technologies have been profiled. Ongoing clini...

USD 250.00

USD 225.00 save 10 %

This edition of the Drug Discovery TOE depicts trends across clinical pharmacogenomics exemplified with prospective innovations worldwide. Although still much research needs to be carried out to leverage genomic information in the development of more personalized and cost-effective strategies in drug discovery and development, the impact of clinica...

USD 950.00

USD 712.50 save 25 %

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across biotherapeutics and genomics. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emp...

USD 250.00

USD 187.50 save 25 %

This edition of the Genetic Technology TOE depicts a range of innovations across personalized genomics specifically across the Indian subcontinent. It provides an overview of some of the major strategic alliances that are happening in India. The companies profiled in this issues, are the current key participants in the personalized genomics space. ...

USD 250.00

USD 187.50 save 25 %

This issue profiles personalized treatment for prostate cancer patients, personal genomics that paves the way for future medicine and health, and gene therapy for ophthalmic diseases.

USD 250.00

USD 187.50 save 25 %

This issue of Vital Signs, released on November 23, 2009, provides a strategic overview of trends in pharmacogenomic testing and drug development. Additionally, a company spotlight is provided for Paratek Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative new therapies that treat and prevent ...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on February 4, 2008, provides an strategic overview of the integration of genomics technology in proteomics analysis. Additionally, a company spotlight is provided for MSM Protein Technologies, an emerging biotechnology company with a suite of tools for drug discovery of functional antibodies and proteins against...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on August 27, 2007, provides a strategic overview of emerging market opportunities for life sciences companies as they relate to direct-to-consumer genetic testing and personal genomics. Additionally, a company spotlight is provided for SeqWright DNA Technology Services, a provider of custom DNA sequencing and re...

USD 1,500.00

USD 1,125.00 save 25 %

This research service outlines the key developments in the field of functional genomics.

USD 4,950.00

USD 3,712.50 save 25 %

20 Dec 2006  |  North America

Strategic Analysis of U.S. Genomics Markets

 

This research service provides a strategic analysis of genomics markets within the United States. The market was divided into the total U.S. nucleic acid isolation markets, total U.S. PCR markets, total U.S. qRT-PCR markets, total U.S. DNA microarray markets, and total U.S. DNA sequencing technology markets. Each segment covers market trends, tech...

USD 4,950.00

USD 3,712.50 save 25 %